Trajan Scientific and Medical has acquired the business of Grale Scientific. Grale, established in 1983, is a leading supplier of pathology consumables and services, based in Melbourne, Victoria, Australia. Stephen Tomisich, Director of the Trajan Group said “Grale is an ideal launching pad for Trajan in Victoria. It’s a great business built around personalized service to pathology laboratories; a strength we intend to build upon.”
The product range of Grale Scientific includes specimen containers, cutting/preparation tools, a broad range of microscope slides, coverslips, reagent products and storage solutions.
Trajan was established in August 2011 with a charter to work with, develop and invest in scientific and medical businesses.
Trajan Scientific and Medical’s hemaPEN® has been independently evaluated and the results of the study published in the Royal Society of Chemistry’s journal Analyst - selected for the cover of issue 17. hemaPEN demonstrated significant advantages for blood sampling to support better healthcare decision making.
Trajan Scientific and Medical has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration as Class I for therapeutic and in vitro diagnostic use. This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.